These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2079243)

  • 1. [Tumor-associated trypsin inhibitor--an expanded tumor marker spectrum in cervix cancer?].
    Medl M; Ogris E; Fuchs G; Leodolter S
    Gynakol Rundsch; 1990; 30 Suppl 1():118-21. PubMed ID: 2079243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Squamous cell carcinoma antigen].
    Nawata S; Sugino N; Kato H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of cancer cells seen in cytodiagnosis of the uterine cervix].
    Amagami Y; Hirata M; Minami A; Uchiyama E
    Rinsho Byori; 1971 Aug; 19():Suppl:94. PubMed ID: 5168195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES; Ermoshina NV; Ageenko AI
    Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytologic charcteristics of histologic forms of cancer of the uterine cervix].
    Botnar' ER
    Arkh Patol; 1977; 39(3):56-63. PubMed ID: 871256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topics in histopathological diagnosis of cancer of the uterine cervix].
    Tsuda H
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():119-22. PubMed ID: 15535218
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumor markers in uterine cancers].
    Fukasawa I; Kousaka N; Kun Z; Inaba N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer].
    Kushlinskiĭ NE; Liubimova NV; Lemeshko AO; Vasil'ev AV; Davydov MI
    Biull Eksp Biol Med; 1997 Jan; 123(1):98-100. PubMed ID: 9213472
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytomorphologic diagnosis of adenogenic cancers of the uterine cervix].
    Novik VI
    Arkh Patol; 1982; 44(9):51-6. PubMed ID: 7150045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between histological pattern and prognosis of squamoadenocarcinoma of the cervix (author's transl)].
    Tang SE
    Zhonghua Fu Chan Ke Za Zhi; 1981 Jan; 16(1):45-7. PubMed ID: 7297236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor marker squamous cell carcinoma antigen].
    Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
    Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection and diagnosis of early uterine cancer].
    Kitao M; Iwanari O
    Nihon Rinsho; 1989 May; 47(5):1158-64. PubMed ID: 2746908
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum tissue polypeptide specific antigen (TPS) in patients with cervical carcinoma: preliminary report.
    Pattaranutaporn P; Chansilpa Y; Tangkarat S; Tepmongkol P; Sangruchi S; Senapad S
    Anticancer Res; 1997; 17(3C):2309-12. PubMed ID: 9216707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma].
    Zhang Y; Liang BL; Gao L; Ye RX; Shen J; Zhong JL
    Ai Zheng; 2007 May; 26(5):508-12. PubMed ID: 17672942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glassy cell carcinoma of the uterine cervix.
    Tanaka T; Ohbayashi F; Shima H; Shimonaka E; Takahashi M
    Pathol Res Pract; 1984 Mar; 178(4):389-94. PubMed ID: 6728721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.
    Mitchell DG; Snyder B; Coakley F; Reinhold C; Thomas G; Amendola M; Schwartz LH; Woodward P; Pannu H; Hricak H
    J Clin Oncol; 2006 Dec; 24(36):5687-94. PubMed ID: 17179104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A; Facchini V; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of RCAS1 as a biomarker of uterine cancer.
    Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoma-derived growth factor is a novel prognostic factor for cervical squamous cell carcinoma.
    Ye F; Cheng Q; Zhou C; Ma J; Chen H
    Histopathology; 2011 May; 58(6):982-4. PubMed ID: 21585431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.